1. Carbenoxolone, in suspension at pH 4.0, inhibits swine pepsin A, and human pepsins 1,3 and 5. Human pepsin 5 is the most readily inhibited, and human pepsin 1 the least.
N. B. Roberts and W. H . Taylor
teolytic activity of normal dogs and of the same dogs after induction of gastric ulceration by cincophen; when the dogs recovered, the normal proteolytic pattern was restored. During further investigation of this difference Taylor (1 970a) observed an increased frequency and raised concentration of pepsin 1 in the gastric juice of patients with gastric and duodenal ulcers as compared with normal subjects (Etherington & Taylor, 1969) . The effect was more marked with gastric ulcer than with duodenal ulcer.
Carbenoxolone (sodium salt) is a triterpene, the di-sodium salt of 3-O-(B-carboxypropionyl)-1 l-oxo-18/3-olean-12-en-30-oic acid. It has been shown by Doll, Hill Hutton & Underwood (1962) , and subsequently by several other groups, to increase the rate of healing of gastric ulcers, but the effect upon duodenal ulceration has been either absent or less marked. It was therefore of interest to study the effect of carbenoxolone upon individual purified human pepsins and pepsinogens and particularly upon pepsin 1. Henman (1970) has already observed that carbenoxolone decreases the total peptic activity of gastric juice obtained from the anaesthetized pylorusligated rat. During the course of the present investigation, Berstad (1972) has reported the inhibition of total peptic activity of normal human gastric juice by carbenoxolone both in vitro and in vivo; in one patient with a duodenal ulcer, carbenoxolone did not decrease the peptic activity of the gastric content. A preliminary account of the present work has been given (Roberts & Taylor, 1973) .
MATERIALS A N D M E T H O D S
Gastric juice was collected by pernasal intragastric tube from patients undergoing augmentedhistamine tests (Kay, 1953) or pentagastrin-stimulation tests, using 6 pg/kg body weight intramuscularly. Pepsins were prepared from human gastric juice and pepsinogens from human gastric mucosal extracts as described previously (Etherington & Taylor, 1969 .
Crystalline swine pepsin, chymotrypsin (bovine pancreas) and bovine haemoglobin substrate powder were obtained from Armour Laboratories, Eastbourne, England; trypsin from Worthington Biochemical Corp., New Jersey, U.S.A. ; Pronase (from Streptomyces griseus) from Koch-Light Laboratories, Colnbrook, England; papain (twice-crystallized) from the Sigma Chemical Co. St Louis, U.S.A. Carbenoxolone (sodium salt) was kindly donated by Dr S . Gottfreid of Biorex Laboratories, London, N.l.
Pepsins and pepsinogens were examined for purity on agar-gel electrophoresis at pH 5.0 (Etherington & Taylor, 1969) . To prevent activation of the zymogens to pepsins, application of the pepsinogen preparations was in phosphate buffer (0.025 mol/l; pH 7.4). Activated pepsinogen fractions and pepsins were applied in acetate buffer (0.025 mol/l; pH 5.0). Measurements of pH were carried out with thevibron pH meter (model 39A, Electronic Instruments Ltd, Richmond, Surrey).
Inhibition of enzymic activity
Solutions or suspensions of carbenoxolone (sodium salt; containing 0-6.5 mmol/l) in sodium phosphate buffers (0.1 mol/l; pH 7.4 or pH %O), phosphate buffer (0.05 mol/l; pH 6.0), or sodium acetate buffer (0.05 mol/l; pH 4.0), were added in a volume of 0.05 ml to 0.05 ml of enzyme solutions in the same respective buffers and at the same pH. Incubation for 30 min at 37°C (unless otherwise stated) was carried out and the residual enzymic activity then determined by adding 1.9 ml of a haemoglobin solution (3.3 g/l) dissolved in the appropriate buffer and at the appropriate pH for the ensuing proteolytic reaction. Control observations were carried out either on enzyme solutions incubated alone, or by rapidly adding the inhibitor and then the substrate to the enzyme solution (zero-time incubation) or by both methods, as appropriate.
Determination of proteolytic activity
The proteolytic activity of pepsins, pepsinogens and their various fractions was determined at pH 2.0 (Etherington & Taylor, 1969) . Zymogens were not activated until they were added to the digestion mixture, which at pH 2.0 gives a rapid conversion of the pepsinogens into pepsins (Seijffers, Segal & Miller, 1963) . The proteolytic activity of chymotrypsin, trypsin, 
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Pronase and papain was measured at pH 7.4 and at pH 8.0 in sodium phosphate buffer (0.1 mol/l). For all these determinations the substrate was bovine haemoglobin (3.3 g/l) and the method that of Anson & Mirsky (1933) , as modified by Hanley Boyer & Naughton (1966) .
Dialysis experiments
Portions (0.3 ml) of solutions of pepsinogens and 0.3 ml of the carbenoxolone solutions at the different concentrations were incubated for 30 min at 37°C and then dialysed at 4°C against a total of 1.5 litres of sodium phosphate buffer (0.1 mol/l) at pH 7.4 or at pH 8.0 for 17 h. Proteolytic activity was measured on 0.1 ml aliquots after dialysis. These solutions now contained so little carbenoxolone that there was no opalescence on bringing the pH to 2.0, at which value carbenoxolone is insoluble.
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RESULTS
Pepsin studies
Carbenoxolone (sodium salt) is readily soluble in water to give a mildly alkaline solution, but in buffered solutions below pH 7-0 it is only poorly soluble. Preliminary experiments indicated that the very small amounts of carbenoxolone that are dissolved at pH 4.0 (the upper end of the pH-activity range of the pepsins) did not inhibit human pepsins 1 and 3. Incubation of each of these pepsins with increasing concentrations of carbenoxolone (sodium salt) in water, up to 6.5 mmol/l, gives increasing inhibition of proteolytic activity ( Fig. l) , but this inhibition results from the increasing pH, for the curve follows closely that of alkaline inactivation in the absence of carbenoxolone. It is possible that the in vitro inhibition by carbenoxolone of swine pepsin, reported by Henman (1970), can be partly explained in this way, since the pH of the final reaction mixtures is not stated. Fig. 2 records the inhibition at pH 4.0 of human pepsins 1, 3 and 5, and at pH 4.0 and pH 6.0 of swine pepsin A after incubation with increasing concentrations of carbenoxolone (sodium salt), which is in non-flocculant suspension at pH 6.0 but is flocculant at pH 4-0.
Under these experimental conditions, pepsin 1 retains activity better than the other pepsins. Inhibition of swine pepsin A, which is analogous to human pepsin 3, was more marked at pH 4.0 than at pH 6.0. In a subsequent series of experiments, human pepsins 1 and 3 were preincubated with suspensions of carbenoxolone at pH 4.0 for 20 min at 37°C. After centrifuging at lo00 g for 2 min, the pellet was washed with 0.1 ml of sodium acetate buffer (0.05 mol/l; pH 4-0), recentrifuged, and the washings added to the first supernatant. The proteolytic activities of the pellet and the combined supernatant were then examined separately. For human pepsin 3, the lost activity of the supernatant could be recovered partially from the pellet, but little of the human pepsin 1 was recovered in this way. For example, at an inhibitor concentration of 1.61 mmol/l (1-0 mg/ml) the supernatant containing pepsin 3 showed only 0.5% of the activity of the uninhibited enzyme, but 38.7% of the lost activity was in the pellet; for pepsin 1, 53.1% of the
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original activity remained in the supernatant and only 4.8% was in the pellet. Once again the degree of inhibition of pepsin 3 in pellet plus supernatant was greater than that of pepsin 1. Although the pellet of carbenoxolone was of greater mass in the more-concentrated solutions, the quantity of recovered pepsin did not increase with mass. Indeed, with pepsin 3 the value fell.
The observations with pepsins would be most readily explained if carbenoxolone inhibits irreversibly some of the pepsin molecules, but binds with others without inhibiting them. The extent of the irreversible inhibition is greater with pepsin 3 than with pepsin 1. Fig. 3 shows the time-course of inhibition of human pepsin 3 by different concentrations (in suspension) of carbenoxolone. The loss of activity is not produced by an instantaneous precipitation, adsorption or denaturation of the enzyme, but by a time-dependent process. The effect of increasing concentrations of carbenoxolone is again confirmed.
The inhibitory process is temperature-dependent. Thus on incubation of carbenoxolone with human pepsin 3 at T C , no inhibition was observed at inhibitor concentrations of up to 6.5 mmol/l (4 mglml); at 23"C, 28% inhibition was obtained at a concentration of 6.5 mmol/l, whereas at 37"C, 71% inhibition was achieved at an inhibitor concentration of only 1.61 mmol/l.
Pepsinogen studies
Working with suspensions of an inhibitor is unsatisfactory. It is possible, however, to study the effect of carbenoxolone upon gastric mucosal pepsinogens at pH 7.4 and pH 8.0, at which values it is much more stable. Fig. 4 shows that incubation at pH 7.4 of an unactivated gastric mucosal extract for 40 min with increasing concentrations of carbenoxolone gives increasing inhibition of the subsequent activation of total pepsinogens. In this experiment the unaffected pepsinogen molecules are activated by the addition of the haemoglobin substrate at pH 2.0. If the pepsinogens are incubated for 30 min at pH 7.4 and then activated by incubation at pH 2.0 for a further 10 min (the carbenoxolone being now in suspension), the resulting inhibition of total peptic activity is much greater. This experiment indicates that carbenoxolone in solution can inhibit or prevent the conversion of pepsinogens to pepsins, but that the inhibition of pepsins is additional to this. Fig. 5 shows the behaviour of the individual pepsinogen and pepsin fractions during a similar experiment, visualized on agar gel. The precursors of pepsins 1 and 3 are decreased by incubation with increasing amounts of carbenoxolone. Pepsins 1,3 and 5 are progessively decreased in amount, when incubated after activation, but much of the activity is accumulating at the point of application. This is caused by uninhibited pepsins attached to the precipitated carbenoxolone ; the pellet of the earlier experiments. Three pepsinogen fractions purified by DEAE-cellulose chromatography were next investigated. Fraction I contained the precursors of pepsin 5 and of the gastric cathepsins ('pepsin' 7 of Etherington & Taylor, 1967) , fraction 111 the precursor of pepsin 3, and fraction V that of pepsin 1. The fractions are numbered and the pepsinogens identified as described by Etherington mately equal quantities, in terms of activity, of each precursor at pH 7-4 for 30 min at 37°C. The precursors of pepsins 1 and 3 were much more readily inactivated than that of pepsin 5. At pH 8.0 a similar result was obtained.
In a further series of experiments the incubated mixtures of pepsinogens and carbenoxolone were dialysed against phosphate buffer (0.1 mol/l; pH 7-4) in order to remove excess carbenoxolone. There was no significant change in the degree of inactivation. This suggests the reaction of the pepsinogens with carbenoxolone is not readily reversible. 
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Experiments with other proteolytic enzymes
A series of enzymes acting over the pH range 7.0-8.0 was chosen, so that carbenoxolone would remain in solution. Fig. 7 shows that chymotrypsin is at least as sensitive to carbenoxolone in solution as is pepsin 3 to carbenoxolone in suspension. Trypsin, by contrast, was only slightly inhibited at pH 7.4. At pH 8.0, slight activation occurred at low concentrations of carbenoxolone followed by inhibition at higher concentrations. Pronase, from Streptomyces griseus, was slightly inhibited at both pH 7.4 and 8-0; thus at a carbenoxolone concentration of 6.5 mmol/l, 20.5% (pH 7-4) and 20.0% (pH 8.0) inhibition was found. Papain, on the other hand, showed increasing activation with increasing concentration of carbenoxolone, so that at a concentration of 6-5 mmol/l the activity of the enzyme was increased by 23.7% at pH 7.4 and by 32.5% at pH 8.0. Table 1 shows the approximate molecular proportions which are needed to give 50% inhibition of each enzyme. Comparisons between the enzymes are difficult because the relatively low specific activity of chymotrypsin, trypsin, Pronase and papain for their substrates meant that much larger amounts of them had to be used than with the pepsins or pepsinogens. The ratios show clearly, however, that for none of the enzymes is there likely to be a specific inhibition at the active site. They re-emphasize the relative insensitivity of human pepsin 1 to carbenoxolone as compared with its zymogen and the increased sensitivity of trypsin at pH 8.0 as compared with pH 7.4. (Taylor, 1968) ; human pepsin 5, 34 600; human pepsin 3, 37 000; human pepsin 1, 43 800 (Roberts & Taylor, 1972) 
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DISCUSSION
Carbenoxolone is known to be absorbed partly from the stomach (Parke, 1968) . It might thus come into contact with the intracellular pepsinogens during its absorption, or by subsequent entry into the mucosal cells from the blood stream. Assuming an intracellular pH of about 7.0, our experiments would suggest that the intracellular pepsinogens might be partly inactivated by carbenoxolone and that pepsinogen 1 (fraction V) would be particularly sensitive to this effect.
Our experiments suggest also that oral carbenoxolone inhibits pepsins directly when in suspension in the lumen of the stomach. Pepsin 3, the principal pepsin, would be particularly sensitive to this type of inhibition. Our data thus provide two possible complementary mechanisms whereby the pepsins or their precursor might be inhibited by carbenoxolone in vim.
It must next be considered whether either of these mechanisms is likely to be of quantitative significance. No data are available to enable a quantitative assessment of intracellular inactivation to be made. As far as intraluminal inhibition is concerned, we have illustrative data on a single male patient with a duodenal ulcer. His gastric juice (histamine-stimulated) contained a total pepsin activity of 40 mg/lOO ml (as swine pepsin equivalent) at pH 4.0, and 50 mg/lOO ml at pH 2.0. When incubated for 30 min at pH 4.0 with carbenoxolone, it was found that 12.5 mg of carbenoxolone (sodium salt) were required to inhibit, by 50%, 1 mg of 'total pepsin', which was contained in 2.5 ml of histamine-stimulated gastricjuice. At pH 2.0, 37% inhibition was achieved with 8 mg of carbenoxolone (sodium salt) and 1 mg of 'total pepsin', which was contained in 2 ml of the juice. Since the daily dose of carbenoxolone (sodium salt) may be as much as 300 mg, it is apparent that significant, though partial, inhibition of the pepsins of 60-75 ml of gastric juice (histamine-stimulated) might thus be achieved. Berstad (1972) describes a significant decrease (about 3040%) of peptic activity of normal human gastric juice in vivo after instilling 100 mg of carbenoxolone (sodium salt) into the stomach. This degree of inhibition is probably of the same order as in our experiment.
Variations in the protein content of gastric juices will affect the inhibition of pepsins, as carbenoxolone binding to constituents such as albumin, for example, is known to occur (Parke, Pollock & Williams, 1963; Whitehouse, Dean & Halsall, 1967) . The non-pepsin proteins will therefore decrease the effective intragastric inhibition of the pepsins, and might make intracellular inactivation of pepsinogens virtually impossible, since the intracellular protein content is so high. Much will depend upon the localization of carbenoxolone intracellularly. It should be noted, however, from a comparison of Figs. 4 and 6, that carbenoxolone inhibits the activation of the pepsinogens of a gastric mucosal extract, containing many proteins, over a similar concentration range to that for the individual pepsinogens. This observation raises the possibility that the pepsinogens may have a high affinity for carbenoxolone.
The mechanism by which carbenoxolone inactivates the pepsins and pepsinogens must take into account the following facts.
1. The molar ratios of enzyme to inhibitor (Table 1) indicate the absence of specific inhibition of the active site, such as is achieved with pepstatin with a pepsin/pepstatin molar ratio of 1 : 1 (Aoyagi, Kunimoto, Morishima, Takeuchi & Umezawa, 1971).
2. In several instances, notably with pepsin 1 and with pepsinogen 5, increasing the concentration of carbenoxolone does not increase further the degree of inactivation. For these enzymes there is a maximal, though partial, degree of inactivation.
3. Carbenoxolone may bind to some of the pepsin and pepsinogen molecules without inactivating them (Fig. 5) .
4. Carbenoxolone has the general property of binding to proteins.
Carbenoxolone activates papain.
It may be that each pepsin and pepsinogen reacts with or is denatured by carbenoxolone in its own individual way. Alternatively, a general hypothesis to account for the experimental facts may be advanced. Carbenoxolone may bind to proteolytic enzymes, as it binds to proteins generally. The binding sites would be to some extent specific and become fully saturated in the case of those enzymes for which a partial inhibition is the most that can be achieved. The configurational changes brought about by the binding would decrease the activity of each enzyme, perhaps by hindering access of the substrate to the active site, by an amount which is typical for each individual enzyme. In the case of papain, the hypothesis would be extended to suggest that the active centre is becoming more accessible as a result of the configurational changes. In addition to inhibition there is, with pepsin 3 for example, some form of aggregation of the enzyme with the suspended particles of carbenoxolone, without inactivation of the enzyme.
The similar response of the pepsinogens, pepsins and chymotrypsin to carbenoxolone is of interest because these enzymes split the B chain of oxidized insulin at similar sites (Taylor, 1962 (Taylor, , 1968 Roberts & Taylor, 1972) involving the hydrophobic residues, phenylalanine, tyrosine, leucine and valine. Trypsin splits the B chain quite differently, acting only on bonds involving lysine and arginine, and Pronase is described as tryptic-like (Trop & Birk, 1970 ). Yet chymotrypsin and trypsin have similar peptide sequences at the active centre, being serine peptidases, but differ from swine pepsin (Knowles & Wybrandt, 1968; Meitner, 1971) , which is not a serine peptidase and which, unlike the serine peptidases, is not inhibited by diisopropylfluorophosphate (Etherington, 1967) . The similar specificity of the various pepsins and chymotrypsin is thus independent of apparent differences of peptide sequence at the active centre, but is associated with the changes, possibly configurational, induced by binding with carbenoxolone.
The healing effect of carbenoxolone in patients with gastric ulcer is well established, but the mechanism of its action is unclear. It does not appear to influence the secretion of hydrogen ions by the gastric mucosa (Berstad, Peterson & Myren, 1970) and more recent work has focussed attention upon its possible action on mucus (Dean, 1968) and on the turnover rate of gastric mucosal cells (Lipkin, 1970) . Taylor (1959 Taylor ( , 1970a has, however, demonstrated an abnormal pattern of peptic activity in the gastric juice of patients with both gastric and duodenal ulcer, and has suggested (Taylor, 1970b ) that pepsin 1 should be regarded as one of the aetiological factors involved in gastric ulceration. The ability of carbenoxolone readily to inhibit the activation of pepsinogen 1 lends some support to the hypothesis that pepsin 1 is a factor in gastric ulceration, but the ready inhibition of pepsin 3 and the relative resistance of pepsin 1 itself to the inhibitor also emphasizes that the total amount of peptic activity may be important.
